Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | GPA33 |
| Gene Name: | GPA33 |
| Protein Full Name: | Cell surface A33 antigen |
| Alias: | A33; cell surface A33 antigen; glycoprotein A33; glycoprotein A33 (transmembrane) |
| Mass (Da): | 35632 |
| Number AA: | 319 |
| UniProt ID: | Q99795 |
| Locus ID: | 10223 |
| COSMIC ID: | GPA33 |
| Gene location on chromosome: | 1q24.1 |
| Cancer protein type: | UNCLEAR |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | UNCLEAR |
| Number of cancer specimens: | 19625 |
| Percent of cancer specimens with mutations: | 0.38 |
| Mutations observed as inherited: | NA |
| Found in amplified chromosomal regions in human cancers: | NA |
| Deregulated in translocations: | NA |
| Deregulated by viral insertion: | NA |
| Transduced into viral genome: | NA |
| Gene undergoes hypermethylation: | NA |
| Normal role description: | GPA33 is a membrane glycoprotein that may play a role in cell-cell recognition and signalling - its function is unclear. It has been reported to be expressed in more than 95% of human colon cancers, but it is also normally expressed in human colon and small intestine epithelia. |